IRADIMED CORP - Common Stock (IRMD)

CUSIP: 46266A109

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+349,365
Put/Call ratio
26%
SEC-reported price per share
$43.99
Indexed holders
125
Value change
+$14,779,015
Number of buys
77
Open additional details 1 more signal available
Number of sells
50
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
12,797,137

Security key

46266A109

Report period

Q1 2024

Indexed institutions

125

Top holders

10

Ownership snapshot

Top reported holders of IRMD - IRADIMED CORP - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Nine Ten Capital Manageme...
Disclosed value leader
Nine Ten Capital Manageme...
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F Highest disclosed value: $37,946,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Nine Ten Capital Management LLC has the largest disclosed position value at $37.95M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Nine Ten Capital Management LLC's linked filing trail.
Disclosed position value Top 5
Nine Ten Capital Management LLC $37.95M
BlackRock Finance, Inc. $30.95M
Soleus Capital Management, L.P. $30.53M
RENAISSANCE TECHNOLOGIES LLC $27.54M
VANGUARD GROUP INC $20.26M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Nine Ten Capital Management LLC
13F
Company
13F
—
denominator unverified
$37,946,000
799,366 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$30,947,972
651,948 shares
— 31 Dec 2023
Soleus Capital Management, L.P.
13F
Company
13F
—
denominator unverified
$30,532,989
643,206 shares
— 31 Dec 2023
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$27,543,000
580,212 shares
— 31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$20,263,756
426,875 shares
— 31 Dec 2023
RK Capital Management, LLC
13F
Company
13F
—
denominator unverified
$16,158,788
340,400 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
125
Shares
6,716,470
Indexed holders
125
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 indexed holders
117
Q1 2024 indexed holders
125
Indexed holder difference
8
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .